IMV Inc (IMVIF)
0.0002
0.00 (0.00%)
USD |
OTCM |
Jul 05, 09:32
IMV Max Drawdown (5Y): 100.0% for June 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
June 30, 2024 | 100.0% |
May 31, 2024 | 100.0% |
April 30, 2024 | 100.0% |
March 31, 2024 | 100.0% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 100.00% |
November 30, 2023 | 99.99% |
October 31, 2023 | 99.99% |
September 30, 2023 | 99.98% |
August 31, 2023 | 99.97% |
July 31, 2023 | 99.97% |
June 30, 2023 | 99.92% |
May 31, 2023 | 99.92% |
April 30, 2023 | 99.32% |
March 31, 2023 | 99.32% |
February 28, 2023 | 98.96% |
January 31, 2023 | 97.15% |
December 31, 2022 | 97.04% |
November 30, 2022 | 96.41% |
October 31, 2022 | 95.51% |
September 30, 2022 | 93.42% |
August 31, 2022 | 93.42% |
July 31, 2022 | 93.42% |
June 30, 2022 | 92.12% |
Date | Value |
---|---|
May 31, 2022 | 87.09% |
April 30, 2022 | 84.99% |
March 31, 2022 | 84.99% |
February 28, 2022 | 84.99% |
January 31, 2022 | 84.85% |
December 31, 2021 | 82.89% |
November 30, 2021 | 81.06% |
October 31, 2021 | 81.06% |
September 30, 2021 | 81.06% |
August 31, 2021 | 81.06% |
July 31, 2021 | 81.06% |
June 30, 2021 | 80.36% |
May 31, 2021 | 80.36% |
April 30, 2021 | 80.36% |
March 31, 2021 | 80.36% |
February 28, 2021 | 80.36% |
January 31, 2021 | 80.36% |
December 31, 2020 | 80.36% |
November 30, 2020 | 80.36% |
October 31, 2020 | 80.36% |
September 30, 2020 | 80.36% |
August 31, 2020 | 80.36% |
July 31, 2020 | 80.36% |
June 30, 2020 | 80.36% |
May 31, 2020 | 80.36% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
73.00%
Minimum
Jul 2019
100.0%
Maximum
Mar 2024
87.35%
Average
83.87%
Median
Max Drawdown (5Y) Benchmarks
Bionoid Pharma Inc | 99.87% |
Cotinga Pharmaceuticals Inc | 100.00% |
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -473.67 |
Beta (5Y) | 29.52 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 4.34K% |
Historical Sharpe Ratio (5Y) | -0.0214 |
Historical Sortino (5Y) | -1.003 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 85.35% |